S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61

Orthofix Medical Insider Trades

-0.82 (-2.64%)
(As of 12/8/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
94,582 shs
Average Volume
86,619 shs
Market Capitalization
$596.69 million
P/E Ratio
Dividend Yield

Orthofix Medical (NASDAQ:OFIX) Insider Buying and Selling Activity

Insider Ownership

Number Of
Insiders Buying
(Last 12 Months)

Amount Of
Insider Buying
(Last 12 Months)
$236.96 K

Number Of
Insiders Selling
(Last 12 Months)

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get OFIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Orthofix Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Orthofix Medical (NASDAQ OFIX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2021Michael E PaolucciDirectorBuy2,000$31.15$62,300.00  
11/19/2021Catherine M BurzikDirectorBuy1,660$30.27$50,248.20  
11/19/2021Rice DougCFOBuy1,400$30.05$42,070.00  
11/18/2021Jon Carl SerbousekCEOBuy1,670$31.14$52,003.80  
11/18/2021Kimberley A EltingInsiderBuy1,000$30.34$30,340.00  
3/12/2020James F HinrichsDirectorBuy10,000$26.85$268,500.0045,574  
2/27/2020Jon Carl SerbousekCEOBuy2,900$35.48$102,892.0041,728  
10/31/2019Ronald A MatricariaDirectorBuy20,000$42.27$845,400.00133,800  
8/28/2019Brad MasonCEOSell5,805$50.97$295,880.85165,041  
6/13/2019Brad MasonCEOSell8,890$51.11$454,367.90159,053  
5/14/2019Brad MasonCEOSell10,668$53.71$572,978.28165,120  
4/17/2019Brad MasonCEOSell5,949$52.35$311,430.15179,237  
2/19/2019Davide BianchiInsiderSell24,400$65.00$1,586,000.00  
1/15/2019Brad MasonCEOSell5,000$50.13$250,650.00136,601  
11/5/2018Bradley V NiemannInsiderSell387$61.63$23,850.8125,748  
11/2/2018Kimberley A EltingInsiderSell7,000$61.05$427,350.0022,740  
11/2/2018Luke T FaulstickDirectorSell8,450$61.05$515,872.507,129  
11/2/2018Rice DougCFOSell6,057$61.25$370,991.2526,511  
10/11/2018Rice DougCFOSell3,949$55.65$219,761.8532,368  
9/5/2018Brad MasonCEOSell2,500$53.02$132,550.00  
8/7/2018Brad MasonCEOSell2,500$53.27$133,175.00152,541  
7/10/2018Brad MasonCEOSell2,500$58.62$146,550.00134,290  
7/3/2018Bradley V NiemannInsiderSell11,250$57.02$641,475.0026,992  
6/19/2018Davide BianchiInsiderSell14,762$60.00$885,720.0041,260  
6/14/2018Brad MasonCEOSell2,500$57.95$144,875.00143,221  
5/3/2018Ronald A MatricariaDirectorBuy10,000$51.97$519,700.00101,613  
12/11/2017Bradley V NiemannInsiderSell5,547$52.08$288,887.7634,631  
11/28/2017Brad MasonCEOSell5,000$53.48$267,400.00183,053  
11/6/2017Luke T FaulstickDirectorSell4,800$51.22$245,856.007,729  
9/11/2017Bradley V NiemannInsiderSell6,956$49.44$343,904.6440,178  
9/11/2017Rice DougCFOSell7,353$49.46$363,679.3844,743  
8/21/2017Brad MasonCEOSell2,733$48.10$131,457.30188,053  
8/10/2017Raymond FujikawaInsiderSell6,364$47.06$299,489.8431,084  
11/10/2016Brad MasonCEOSell9,538$36.83$351,284.54151,219  
9/1/2016Michael FineganInsiderSell25,000$45.16$1,129,000.0051,670  
6/10/2016Maria SainzDirectorSell4,157$46.33$192,593.8120,828  
6/9/2016Brad MasonCEOSell18,336$46.00$843,456.00160,256  
6/8/2016Bradley V NiemannInsiderSell3,402$44.70$152,069.4025,500  
5/20/2016Robert Allen Goodwin IIInsiderSell13,187$44.00$580,228.0039,607  
4/18/2016Michael FineganInsiderSell80,972$42.71$3,458,314.1290,996  
11/11/2015Michael FineganInsiderSell14,140$42.00$593,880.0058,252  
11/6/2015Brad MasonCEOSell15,018$40.60$609,730.80140,256  
11/6/2015Jeffrey SchumminsiderSell15,000$40.67$610,050.0068,882  
6/2/2015Ronald A MatricariaDirectorBuy50,000$32.65$1,632,500.00  
5/21/2015James F HinrichsDirectorBuy10,000$33.17$331,700.00  
6/10/2014Mark A HeggestadCFOBuy13,696$33.25$455,392.00  
5/17/2013Brad MasonCEOBuy5,000$26.45$132,250.00  
5/17/2013Kenneth R WeisshaarDirectorBuy1,000$26.40$26,400.00  
5/14/2013James GeroDirectorBuy20,000$26.37$527,400.00  
2/27/2013Robert S VatersCEOBuy3,000$35.97$107,910.00  
(Data available from 1/1/2013 forward)

Orthofix Medical (NASDAQ:OFIX) Insider Trade Frequently Asked Questions

Who is on Orthofix Medical's Insider Roster?

The list of insiders at Orthofix Medical includes Brad Mason, Catherine M Burzik, Davide Bianchi, James F Hinrichs, Jon Carl Serbousek, Kimberley A Elting, Michael E Paolucci, Rice Doug, and Ronald A Matricaria.Learn more on OFIX's insiders

What percentage of Orthofix Medical stock is owned by insiders?

4.00% of Orthofix Medical stock is owned by insiders. Learn more on OFIX's insider holdings

Which Orthofix Medical insiders have been buying company stock?

The following insiders have purchased Orthofix Medical stock in the last 24 months: Catherine M Burzik ($50,248.20), James F Hinrichs ($268,500.00), Jon Carl Serbousek ($154,895.80), Kimberley A Elting ($30,340.00), Michael E Paolucci ($62,300.00), and Rice Doug ($42,070.00).

How much insider buying is happening at Orthofix Medical?

Insiders have purchased a total of 20,630 Orthofix Medical shares in the last 24 months for a total of $608,354.00 bought.

This page was last updated on 12/9/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.